Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Heartbeam Inc
(NQ:
BEAT
)
2.790
-0.040 (-1.41%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Heartbeam Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
HeartBeam Reports Third Quarter 2023 Financial Results
November 14, 2023
From
HeartBeam, Inc.
Via
Business Wire
Beat of Life Entertainment's 'Diya Jalao Roshni Lao' Campaign: Lighting Up Lives and Preserving Tradition!
November 13, 2023
The "Diya Jalao Roshni Lao" campaign was initiated by the Beat of Life Entertainment company in 2022. Its aim is to draw people's attention to our culture, the hard work of potters, hope, their lives,...
Via
IssueWire
Topics
Religion
Exposures
Religion
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Expands Scientific Advisory Board as It Advances Product Development, Clinical and Commercial Efforts
November 09, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
HeartBeam Announces Expansion of Its Scientific Advisory Board
November 09, 2023
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam Granted Third US Patent for 12-Lead Extended Wear Patch for Detecting Heart Attacks and Complex Cardiac Arrythmias
November 07, 2023
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Third Quarter 2023 Results Conference Call
October 31, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
HeartBeam to Host Third Quarter 2023 Results Conference Call on Tuesday November 14, 2023 at 4:30 p.m. Eastern Time
October 31, 2023
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Experienced Leaders to New Senior Management Positions
September 26, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
HeartBeam Appoints Richa Gujarati and Pooja Chatterjee to Senior Management Team
September 26, 2023
From
HeartBeam, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
September 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 31, 2023
Via
Benzinga
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q2 2023 Financial Report, Corporate Update
August 11, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Product Safety
HeartBeam Reports Second Quarter 2023 Financial Results
August 10, 2023
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces First Peer-Reviewed Publication Based on Its VECG Technology
August 09, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
HeartBeam Announces Publication of Foundational Study on the Detection of Heart Attacks
August 09, 2023
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints Deborah Castillo to Lead Regulatory Strategy and Execution
August 08, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
HeartBeam Appoints Deborah Castillo as Vice President of Regulatory Affairs
August 08, 2023
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q2 2023 Results Call, Webcast
July 27, 2023
Via
Investor Brand Network
HeartBeam to Host Second Quarter 2023 Results Conference Call on Thursday August 10, 2023 at 4:30 p.m. Eastern Time
July 27, 2023
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Experienced Physician, Researcher to Board of Directors
July 26, 2023
Via
Investor Brand Network
HeartBeam Appoints Dr. Michael R. Jaff to the Board of Directors
July 26, 2023
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Adds Wealth of Expertise to Its Board with Appointments of Ken Nelson and Mark Strome
June 08, 2023
Via
Investor Brand Network
HeartBeam Appoints Ken Nelson and Mark Strome to the Board of Directors
June 08, 2023
From
HeartBeam, Inc.
Via
Business Wire
Strategic Alliance with Samsung and Collaboration with Dept. of Veterans Affairs to Advance Use of Unique 3-D Telehealth Technology for Heart Attack Detection and Quicker Response: BEAT
May 30, 2023
Via
Get News
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Enters SAA with Samsung
May 30, 2023
Via
Investor Brand Network
Exposures
Product Safety
Monitoring Cardiac Symptoms? HeartBeam Extends Pact With Samsung For LIVMOR Solutions
May 30, 2023
Via
Benzinga
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Enters SAA with Samsung
May 30, 2023
Via
Investor Brand Network
Exposures
Product Safety
HeartBeam (NASDAQ: BEAT) Enters Strategic Alliance Agreement with Samsung for Cardiac Care Solutions
May 30, 2023
HeartBeam Collaborates with Samsung to Boost Cardiac Diagnostic Capabilities HeartBeam, Inc. (NASDAQ: BEAT), renowned for their pioneering 3D-vector electrocardiogram (VECG)
Via
Spotlight Growth
Exposures
Product Safety
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 30, 2023
Via
Benzinga
HeartBeam Enters into Strategic Alliance Agreement with Samsung
May 30, 2023
From
HeartBeam, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.